The therapeutic applications of exosomes, particularly those derived from stem cells and cancer cells, continue to expand in 2025, driving accelerated innovation in this dynamic market. Emerging trends highlight the potential of exosomes as both diagnostic tools and cell-free therapeutics, with increasing applications across diverse fields such as oncology, neurology, and regenerative medicine. In parallel, a growing number of life science companies are providing advanced tools and reagents to support exosome research, reflecting the sector’s rapid growth. [Read more…]
The Booming Market for Exosomes in 2025
Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. [Read more…]
The Dominance of Cell and Gene Therapy CDMOS in 2025
While there are many exciting market segments, the market for cell and gene therapy CDMO services is one of the most fascinating. A decade ago, there were only a handful of market competitors. Today, there are more than a hundred companies specializing in manufacturing and clinical trial support for cell and gene therapies (CGT)—and demand for their services continues to rise. [Read more…]
What Is the Future of the Stem Cell Market in 2025?
Stem cell therapy continues to rally worldwide recognition as governments fund research and expand access. This once-controversial therapy is fast becoming one of medicine’s most exciting technologies. From FDA-approved therapies to in-house, physician-initiated autologous techniques, stem cell technology continues to evolve. 2025 promises to be an exciting year for the stem cell market.
Here’s everything you need to know about the future of this revolutionary therapy. [Read more…]
Opening Cancer’s Mail: Cancer Exosomes Contain “Inventory of Intent”
Currently over 50% of men and women are directed to unnecessary treatment or surgery. A new approach may help. Professor Alan Doucette of Dalhousie University and his colleagues have published a study funded by the Breast Cancer Society of Canada in which they capture particles released by rapidly growing cells called exosomes. Like parcels containing tools and instructions, exosomes contain an “inventory of intent.” Meaning, the cells that have released them contain genetic material proteins and metabolites that promote invasion of normal cells and commandeer their resources. [Read more…]
- « Previous Page
- 1
- …
- 68
- 69
- 70
- 71
- 72
- …
- 334
- Next Page »